BioSpace News Archive

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 13th Annual Wells Fargo Securities Healthcare Conference on Thursday, September 6, 2018, in Boston.

Over the past 25 years, globalization of drug manufacturing has prompted the FDA to change its regulatory landscape.

Young Living Essential Oils, the world leader in essential oils, today introduced YL Go, a two-tiered, annual subscription shipping program available exclusively to its Essential Rewards members in the United States, which provides subscribers up to 36 free shipments each year and priority processing for their favorite Young Living Essential Oils orders.

Workpath, a healthcare technology company that helps organizations distribute work opportunities to their employees and third-party networks, announced today that it has been selected as a Top 10 Healthcare Startup for 2018 by Healthcare Tech Outlook magazine.

SenzaGen (Nasdaq First North: SENZA) announces today that the Company is now expanding its market focus to the medical device market.

BioAscent Discovery Limited (www.bioascent.com) has announced the appointments of Angus Morrison, PhD, as Director of Chemistry and Stuart McElroy, PhD, as Director of Biosciences, to oversee the development and delivery of BioAscent’s integrated drug discovery services.

Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery technologies, today announced that Jerry McLaughlin, Chief Executive Officer of Neos Therapeutics, will present a company overview at the upcoming Wells Fargo 2018 Healthcare Conference on Wednesday, September 5, 2018 at 2:25 p.m. ET in Boston, MA.

Catalyst Pharmaceuticals, Inc. today announced that Patrick J. McEnany, Chief Executive Officer, and Steven Miller, Ph.D., Chief Operating Officer and Chief Scientific Officer, will be presenting at Rodman & Renshaw’s 20th Annual Global Investment Conference, which is being held on September 4-6, 2018 at the St. Regis New York Hotel in New York City.

Company takes a stand to reinvigorate soccer by giving children freedom to enjoy sports through organized pick up play

Compugen Ltd. announced today the appointment of Jean-Pierre Bizzari, M.D., formerly Executive Vice President and Global Head of Oncology at Celgene Corporation, to its Board of Directors.